Public archive
Cantor Fitzgerald raises its price target on Elevance Health (ELV) to $450 from $400 (7 Jul 2026)
Updated November 14, 2026
Cantor Fitzgerald raises its price target on Elevance Health (ELV) to $450 from $400 on 7 July 2026. That is a 12.5% increase, and the firm keeps its Overweight rating.
Event data
- Company
- Elevance Health
- Ticker
- ELV
- Exchange
- NYSE
- Analyst Firm
- Cantor Fitzgerald
- Rating Action
- price target change
- New Rating
- overweight
- Old Price Target
- $400
- New Price Target
- $450
- Price Target Currency
- USD
- Price Target Change Percent
- +12.5%
- Sector
- Healthcare
- Country
- United States
Subscribers saw this 17 days earlier.
Source
themarketsdaily.com